Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intensive surveillance after CRC resection does not improve survival

Publish date:: October 13, 2020

Key clinical point: Intensive surveillance with carcinoembryonic antigen testing and CT scans after colorectal cancer resection did not improve survival when compared with standard abdominal ultrasound/chest x-ray monitoring in a phase 3 trial.

Major finding: At a median follow-up of 6.5 years, there were no significant differences in 5-year overall survival (P = .340) or recurrence-free survival (P = .473).

Study details: A phase 3 trial of 1,995 patients with stage II/III colorectal cancer who underwent resection with curative intent.

Disclosures: The study is ongoing and being funded by the Federation Francophone de Cancerologie Digestive. Dr. Lepage disclosed ties with Novartis, Amgen, Bayer, Servier, and AAA.

Citation:

Lepage C et al. ESMO 2020, Abstract 398O.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Upper GI bleeds in COVID-19 not related to increased mortality,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,